Skip to main content
OpenTrials
Completed

NCT Number: NCT06723340

Dermatological Assessment of Primary Dermal Irritability Accumulated, Sensitization, Photoallergy and Photosensitization of a Scar Gel

Evaluate the potential of Primary Dermal Irritability, Accumulated Dermal Irritability, Dermal Sensitization, Photoallergy and Photosensitization, of health products through the application of Patch Test, proving the safety of the product for topical use. The study will be conducted with a Brazilian sample in which 55 research participants will be included. Depending on the results, the present study may support the claim: dermatologically tested, non-irritating, non-sensitizing, non-photoirritating and non-photosensitizing.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Medcin Instituto da Pele Ltda

Osasco, São Paulo, Brazil

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants of both sexes aged 18 to 70 years;
  • Phototypes: I, II, III, and IV (For the phototest trial, only phototypes II and III will be considered);
  • Intact skin in the application area;
  • Willingness to follow the trial procedures and attend the center on the specified dates and times for medical evaluations and for application and reading of dressings;
  • Understanding, consent, and signing of the Informed Consent Form (ICF).

Exclusion criteria

  • Pregnancy or risk of pregnancy/lactation;
  • Use of anti-inflammatory drugs within 30 days and/or immunosuppressive drugs up to three months before selection;
  • Immunosuppression due to drugs or active diseases;
  • Uncompensated endocrinopathies;
  • Personal history of atopy;
  • Intense sun exposure or tanning sessions up to 15 days before the evaluation or during the study period;
  • Plans to bathe in the sea, pool, or sauna during the study;
  • Practice of water sports during the study;
  • Dermographism;
  • Use of oral or topical treatments with vitamin A acid and/or its derivatives up to one month before the start of the study;
  • Aesthetic and/or dermatological treatments on the body within three weeks prior to selection;
  • Scheduled vaccination during the study period or within three weeks prior to selection;
  • History of sensitization, irritation, or photosensitization to topical products;
  • Active skin conditions (local and/or widespread) that could interfere with study results;
  • Skin reactivity;
  • Use of new medications during the study;
  • Previous participation in studies with the same product;
  • Congenital or acquired immunodeficiency;
  • Clinically significant or current evidence of alcohol or drug abuse;
  • Known or suspected history of intolerance to any ingredient in the study product;
  • History of non-adherence or unwillingness to adhere to the study protocol;
  • Employees of Medcin or the sponsoring company involved in the study, or close family members of an employee involved in the study;
  • Other conditions deemed reasonable by the researcher for disqualification from study participation. If applicable, this must be noted in the clinical record.

Exclusion criteria

for the Phototest:

  • Previous history of conditions exacerbated or triggered by ultraviolet radiation;
  • Use of photosensitizing drugs;
  • History or presence of photodermatoses;
  • Personal or family history of skin cancer.

Treatment and study plan

Scar gel

Device

Scar gel (medical device - topical application)

Primary outcomes

  1. Absence

    Time frame: 9 weeks

    Absence of Primary Dermal Irritability Accumulated, Sensitization, Photoallergy and Photosensitization under normal conditions and when exposed to sunlight.

Sponsors and collaborators

Lead sponsor

Herbarium Laboratorio Botanico Ltda

Industry

Registry information

Official study title

Dermatological Assessment of Primary Dermal Irritability Accumulated, Sensitization, Photoallergy and Photosensitization Under Normal Conditions and When Exposed to Sunlight of a Scar Gel

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Dec 9, 2024
Registry last updated
Mar 14, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.